219 related articles for article (PubMed ID: 29586541)
1. The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery.
Szalewski DA; Hinrichs VS; Zinniel DK; Barletta RG
Can J Microbiol; 2018 Jul; 64(7):439-453. PubMed ID: 29586541
[TBL] [Abstract][Full Text] [Related]
2. The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance.
Brown NA; Goldman GH
J Microbiol; 2016 Mar; 54(3):243-53. PubMed ID: 26920884
[TBL] [Abstract][Full Text] [Related]
3. New insights into invasive aspergillosis--from the pathogen to the disease.
Binder U; Lass-Flörl C
Curr Pharm Des; 2013; 19(20):3679-88. PubMed ID: 23278533
[TBL] [Abstract][Full Text] [Related]
4.
Durieux MF; Melloul É; Jemel S; Roisin L; Dardé ML; Guillot J; Dannaoui É; Botterel F
Virulence; 2021 Dec; 12(1):818-834. PubMed ID: 33682618
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus fumigatus: contours of an opportunistic human pathogen.
McCormick A; Loeffler J; Ebel F
Cell Microbiol; 2010 Nov; 12(11):1535-43. PubMed ID: 20716206
[TBL] [Abstract][Full Text] [Related]
6. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
[TBL] [Abstract][Full Text] [Related]
7. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A; Sharma C; Hagen F; Meis JF
Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
[TBL] [Abstract][Full Text] [Related]
8. Changes in the epidemiological landscape of invasive mould infections and disease.
Lass-Flörl C; Cuenca-Estrella M
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
[TBL] [Abstract][Full Text] [Related]
9. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.
Ben-Ami R; Lewis RE; Kontoyiannis DP
Br J Haematol; 2010 Aug; 150(4):406-17. PubMed ID: 20618330
[TBL] [Abstract][Full Text] [Related]
10. A Nonredundant Phosphopantetheinyl Transferase, PptA, Is a Novel Antifungal Target That Directs Secondary Metabolite, Siderophore, and Lysine Biosynthesis in
Johns A; Scharf DH; Gsaller F; Schmidt H; Heinekamp T; Straßburger M; Oliver JD; Birch M; Beckmann N; Dobb KS; Gilsenan J; Rash B; Bignell E; Brakhage AA; Bromley MJ
mBio; 2017 Jul; 8(4):. PubMed ID: 28720735
[TBL] [Abstract][Full Text] [Related]
11. Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance.
Kashyap VH; Mishra A; Bordoloi S; Varma A; Joshi NC
Mycoses; 2023 Sep; 66(9):737-754. PubMed ID: 37212186
[TBL] [Abstract][Full Text] [Related]
12. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
13. Implications of hypoxic microenvironments during invasive aspergillosis.
Wezensky SJ; Cramer RA
Med Mycol; 2011 Apr; 49 Suppl 1(Suppl 1):S120-4. PubMed ID: 20560863
[TBL] [Abstract][Full Text] [Related]
14. cipC is important for Aspergillus fumigatus virulence.
Canela HM; Takami LA; da Silva Ferreira ME
APMIS; 2017 Feb; 125(2):141-147. PubMed ID: 28120495
[TBL] [Abstract][Full Text] [Related]
15. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
Negri CE; Gonçalves SS; Sousa ACP; Bergamasco MD; Martino MDV; Queiroz-Telles F; Aquino VR; Castro PTO; Hagen F; Meis JF; Colombo AL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893772
[No Abstract] [Full Text] [Related]
16. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
Alanio A; Denis B; Hamane S; Raffoux E; Peffault de Latour R; Menotti J; Amorim S; Touratier S; Bergeron A; Bretagne S
Emerg Infect Dis; 2016 Jan; 22(1):157-8. PubMed ID: 26690934
[No Abstract] [Full Text] [Related]
17. [Causative Agents of Aspergillosis Including Cryptic Aspergillus Species and A. fumigatus].
Toyotome T
Med Mycol J; 2016; 57(4):J149-J154. PubMed ID: 27904060
[TBL] [Abstract][Full Text] [Related]
18. Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin.
Laskaris P; Atrouni A; Calera JA; d'Enfert C; Munier-Lehmann H; Cavaillon JM; Latgé JP; Ibrahim-Granet O
Antimicrob Agents Chemother; 2016 Oct; 60(10):5631-9. PubMed ID: 27401578
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
Lamoth F; Juvvadi PR; Steinbach WJ
Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
[TBL] [Abstract][Full Text] [Related]
20. Home Environment as a Source of Life-Threatening Azole-Resistant Aspergillus fumigatus in Immunocompromised Patients.
Lavergne RA; Chouaki T; Hagen F; Toublanc B; Dupont H; Jounieaux V; Meis JF; Morio F; Le Pape P
Clin Infect Dis; 2017 Jan; 64(1):76-78. PubMed ID: 27682064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
